# Observational Trial Evaluating Elevated Factor VIII Related Labs as a Biomarker for Incomplete Relapse Recovery

> **NCT05926167** · — · UNKNOWN · sponsor: **Dignity Health Medical Foundation** · enrollment: 9 (estimated)

## Conditions studied

- Multiple Sclerosis
- Relapse

## Interventions

- **DIAGNOSTIC_TEST:** blood tests drawn days 1, 8, 22 and 90 of the study

## Key facts

- **NCT ID:** NCT05926167
- **Lead sponsor:** Dignity Health Medical Foundation
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-09-12
- **Primary completion:** 2024-05
- **Final completion:** 2024-12
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2023-09-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05926167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05926167, "Observational Trial Evaluating Elevated Factor VIII Related Labs as a Biomarker for Incomplete Relapse Recovery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT05926167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*